References
Brooklyn T, Dunhill G, Probert C (2006) Diagnosis and treatment of pyoderma gangrenosum. BMJ 333:181–184
Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF 3rd et al (1998) Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 111:259–268
Callen JP, Jackson JM (2007) Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 33:787–802
von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow up. Br J Dermatol 137:1000–1005
Yayli S, Bahadir S, Alpay K, Cimsit G, Cobanoglu U, Tosun M (2005) Pyoderma gangrenosum in association with juvenile rheumatoid arthritis. J Dermatol 32:827–830
Brown TS, Marshall GS, Callen JP (2000) Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 43:108–112
Yoshida C, Kojima H, Shigaki T, Katsura Y, Kaneko S, Suzukawa K et al (2004) Association of pyoderma gangrenosum and sterile osteomyelitis in a patient having myelodysplastic syndrome with der (1;7)(q10;q10). Eur J Haematol 72:149–153
Su WP, Schroeter AL, Perry HO, Powell FC (1986) Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 13:323–330
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chandrasekhara, P.K.S., Jayachandran, N.V., Thomas, J. et al. Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone. Clin Rheumatol 28, 489–490 (2009). https://doi.org/10.1007/s10067-008-1066-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-1066-y